Shares of MBX Biosciences, Inc. (MBX) have gained 2.6% over the past four weeks to close the last trading session at $17.96, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$59 indicates a potential upside of 228.5%.The average comprises eight short-term price targets ranging from a low of $30.00 to a high of$84.00, with a standard deviation of $17.91. While the lowest estimate ...